or
forgot password
  • cancer clinical trials in la porte, IN

  • Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Lung Cancer
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Malignant Mesothelioma
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Colorectal Cancer
    Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Kidney Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Michiana Hematology Oncology PC - La Porte
    La Porte, Indiana 46350
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Prostate Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Breast Cancer, Cancer Survivor, Hot Flashes
    Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
    Michiana Hematology Oncology PC - La Porte
    La Porte, Indiana 46350
    Breast Cancer
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Armodafinil in Reducing Cancer-Related Fatigue in Patients With Glioblastoma Multiforme
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Fatigue
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Anal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Melanoma (Skin)
    Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Bladder Cancer
    Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer, Osteoporosis
    Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Sarcoma
    Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer, Hot Flashes
    Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Kidney Cancer
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Head and Neck Cancer
    Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Pancreatic Cancer
    Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Extensive Stage Small Cell Lung Cancer
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Pancreatic Cancer
    Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Gestational Trophoblastic Tumor, Neurotoxicity, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lymphoma
    Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Cervical Cancer
    Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Vulvar Cancer
    Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer
    Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lymphoma
    Levocarnitine in Treating Fatigue in Cancer Patients
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific